{"title": "Seguridad y eficacia de una vacuna COVID 19 prime-boost heter\u00f3loga, basada en un vector rAd26 y rAd5: un an\u00e1lisis provisional de un ensayo de fase 3, controlado, aleatorio, en Rusia - INFOMED", "author": "Ramiro Heredia", "url": "https://infomed.com.ar/seguridad-y-eficacia-de-una-vacuna-covid-19-prime-boost-heterologa-basada-en-un-vector-rad26-y-rad5-un-analisis-provisional-de-un-ensayo-de-fase-3-controlado-aleatorio-en-rusia/", "hostname": "infomed.com.ar", "description": "Se public\u00f3 el 2 de febrero, en The Lancet, la Fase 3 del ensayo de la vacuna Covid-19 Sputnik V: mostr\u00f3 una eficacia del 91.6 % contra el Covid-19, con gran seguridad, en una importante cohorte, con una eficacia superior en mayores de 60 a\u00f1os y protecci\u00f3n del 100 % contra el Covid-19 grave.", "sitename": "INFOMED", "date": "2021-02-06", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Se public\u00f3 el 2 de febrero, en The Lancet, la Fase 3 del ensayo de la vacuna Covid-19 Sputnik V: mostr\u00f3 una eficacia del 91.6 % contra el Covid-19, con gran seguridad, en una importante cohorte, con una eficacia superior en mayores de 60 a\u00f1os y protecci\u00f3n del 100 % contra el Covid-19 grave.\nLa vacuna rusa contra el Covid-19, Sputnik V (no el 5 de los n\u00fameros romanos, es \u201cV\u201d de vacuna), nombre elegido por ser uno de los emblemas de la Federaci\u00f3n Rusa, en su carrera aeroespacial, para aprovechar la fama mundial que implica ese nombre y aumentar la aceptaci\u00f3n universal, o su nombre t\u00e9cnico, Gam-COVID-Vac, fue la primer vacuna presentada al mundo contra el SARS-COV-2.\nEl anuncio de que Rusia contaba con la vacuna contra el coronavirus y que ya estaba aprobada para uso de emergencia, data de fines de agosto. El 4 de septiembre, el grupo de cient\u00edficos liderado por el Profesor Lagunov, del Instituto Nacional Central de Investigaci\u00f3n de Epidemiolog\u00eda y Microbiolog\u00eda N F Gamaleya, public\u00f3 en The Lancet Seguridad e inmunogenicidad de una vacuna Covid-19 rAd26 y rAd5, heter\u00f3loga, prime-boost, basada en vectores, en dos formulaciones, fases 1/2 del estudio, abierto, no aleatorizado, de Rusia . Ac\u00e1 resum\u00edan las fases 1/2 de su ensayo, sobre 76 voluntarios adultos, sanos, de 18 a 60 a\u00f1os, evaluados durante 45 d\u00edas. Se dividieron en 2 grupos de 38 individuos. En cada uno, 9 voluntarios recibieron rAd5-S en fase 1 y 20 recibieron rAd26-s en fase 2. La vacuna utiliza 2 vectores de adenovirus recombinantes, portadores del gen de la glicoprote\u00edna S del SARS-CoV-2, de aplicaci\u00f3n intramuscular, con requerimiento de un refuerzo primario, en 2 presentaciones.\nLos resultados primarios, que fueron la generaci\u00f3n de anticuerpos espec\u00edficos contra en SARS-CoV-2, y la seguridad, se alcanzaron: ambas formulaciones fueron seguras y bien toleradas, y todos produjeron anticuerpos anti S, neutralizantes. Como resultado secundario, la respuesta inmune celular mediada por c\u00e9lulas T, tambi\u00e9n se alcanz\u00f3.\nEsto result\u00f3 promisorio, pero segu\u00eda faltando la p\u00fablicaci\u00f3n de la fase 3 del ensayo, y su revisi\u00f3n por pares. El 7 de septiembre, un grupo de 40 cient\u00edficos en el Blog del Profesor Enrico Bucci, de Italia, publicaron una Carta Abierta dirigida a Logunov y al editor de The Lancet: reclamaban el acceso a los datos fuente, que no hab\u00edan sido publicados. Encontraron ciertas potenciales inconsistencias, como la duplicaci\u00f3n de resultados y valores exactamente iguales de anticuerpos en distintos participantes, situaci\u00f3n pr\u00e1cticamente inveros\u00edmil, as\u00ed como las caracter\u00edsticas de los pacientes del grupo comparador convaleciente que utilizaron.\nLa revista Nature, en una publicaci\u00f3n del 24 de septiembre, Los investigadores cuestionan los resultados del ensayo de la vacuna Covid rusa relata muy bien esto. Pas\u00f3 el tiempo, llegaron las publicaciones de las fases 3 de los ensayos de Pfizer-BioNTech Moderna, y Oxford-AstraZeneca, muy seguras y eficaces, con la aprobaci\u00f3n e inicio de la vacunaci\u00f3n en Estados Unidos y en gran parte del mundo. Mientras tanto, en otros pa\u00edses, como el nuestro, se comenz\u00f3 a aplican la vacuna rusa, gran pol\u00e9mica por la falta de datos publicados y revisados por pares.\nFinalmente el 2 de febrero del 2021, se public\u00f3 en la prestigiosa revista The Lancet Seguridad y eficacia se una vacuna Covid-19 prime-Boost heter\u00f3loga, basada en un vector rAd26 y rAd5: una an\u00e1lisis provisional de un ensayo de fase 3, controlado, aleatorizado, en Rusia . El ensayo fue doble ciego, aleatorizado, controlado con placebo, multic\u00e9ntrico (25 centros de salud de Mosc\u00fa), e incluyeron casi 22 mil pacientes mayores de 18 a\u00f1os, de hasta 87 a\u00f1os, con una edad media de 45.3 a\u00f1os. Se asignaron al azar en una relaci\u00f3n 3:1 a recibir vacuna o placebo (75 % recibieron la vacuna), v\u00eda intramuscular, en un r\u00e9gimen de cebado-refuerzo, con una primer dosis (rAd26) y una segunda dosis (rAd5) a los 21 d\u00edas, con ambos vectores portando el gen de la glicoprote\u00edna S del SARS-CoV-2.\nEl resultado primario, proporci\u00f3n de participantes con Covid-19 confirmado desde el d\u00eda 21 de la primer dosis: 0.1% (16) de los participantes del grupo vacuna versus 1.3 % (63) de los participantes del grupo placebo hab\u00edan contra\u00eddo Covid-19, lo que arrojo una eficacia de la vacuna del 91.6%, y 91.8 % en el subgrupo de mayores de 60 a\u00f1os. Luego de la primer dosis, la eficacia de la vacuna para proteger del Covid-19, en cualquier momento, fue del 73.6 %. C\u00f3mo resultados secundarios, la protecci\u00f3n contra la enfermedad grave, que arrojo un 100 % de protecci\u00f3n en el grupo analizado a d\u00eda 21, y entre los 15 y 21 d\u00edas de la primera dosis, la eficacia fue del 73.7%.\nNo hubo eventos adversos graves atribuibles a la vacuna. Se describen ac\u00e1 adem\u00e1s los resultados iniciales de inmunogenicidad, que muestra que el r\u00e9gimen de vacunaci\u00f3n con dos vectores adenovirales distintos proporciona fuertes respuestas inmunes celulares, y una generaci\u00f3n de AC neutralizantes en el 98 % de los pacientes. El estudio incluy\u00f3 a 1369 mayores de 60 a\u00f1os que recibieron las 2 dosis de la vacuna, en los que se vi\u00f3 una eficacia ligeramente mayor y excelente perfil de seguridad. Otro dato importante, la vacuna se almacena a a 2-8 grados cent\u00edgrados, lo que facilita su distribuci\u00f3n global.\n\u00bfQuer\u00e9s recibir Novedades? Suscribite Gratis\nSuscribite a nuestro Newsletter semanal para recibir todas las novedades sobre el mundo de la medicina en espa\u00f1ol.", "language": null, "image": "https://infomed.com.ar/wp-content/uploads/2021/02/infomed-medicina-novedades-covid-vacuna-sputnik.jpg", "pagetype": "article", "links": ["#", "https://infomed.com.ar/usar-sabiamente-los-antibioticos-para-las-infecciones-del-tracto-respiratorio-en-la-era-del-covid-19/", "https://infomed.com.ar/vacuna-sinopharm-para-ninos-y-adolescentes-cual-es-la-ultima-evidencia/", "https://infomed.com.ar/mas-de-50-efectos-a-largo-plazo-del-covid-19-una-revision-sistematica-y-meta-analisis/", "https://infomed.com.ar/", "#", "https://infomed.com.ar/ultimos-titulos/", "https://infomed.com.ar/category/cardiologia/", "https://infomed.com.ar/category/covid-19/", "https://infomed.com.ar/category/covid-19/diagnostico/", "https://infomed.com.ar/category/covid-19/politicas/", "https://infomed.com.ar/category/covid-19/post-covid/", "https://infomed.com.ar/category/covid-19/tratamiento/", "https://infomed.com.ar/category/covid-19/vacunas/", "https://infomed.com.ar/category/covid-19/variantes/", "https://infomed.com.ar/category/endocrinologia/", "https://infomed.com.ar/category/ginecologia/", "https://infomed.com.ar/category/infectologia/", "https://infomed.com.ar/category/inmunologia/", "https://infomed.com.ar/category/medicina-del-sueno/", "https://infomed.com.ar/category/nefrologia/", "https://infomed.com.ar/category/neurologia/", "https://infomed.com.ar/category/nutricion/", "https://infomed.com.ar/category/oncologia/", "https://infomed.com.ar/category/pacientes/", "https://infomed.com.ar/category/pediatria/", "https://infomed.com.ar/category/podcast/", "https://infomed.com.ar/category/politica-sanitaria/", "https://infomed.com.ar/category/psicologia/", "https://infomed.com.ar/category/psiquiatria/", "https://infomed.com.ar/category/sexologia/", "https://infomed.com.ar/category/tecnologia/", "https://infomed.com.ar/category/traumatologia-y-ortopedia/", "https://infomed.com.ar/category/toxicologia/", "https://infomed.com.ar/category/video/", "https://infomed.com.ar/registro/", "https://infomed.com.ar/nosotros/", "https://infomed.com.ar/contacto/", "https://www.priorityhomecaresrl.com.ar/?utm_source=bannerad&utm_medium=marfer", "http://www.feraval.com/?ref=infomed", "https://www.gedyt.com.ar/?ref=infomed", "https://infomed.com.ar/author/ramiro-heredia/", "https://infomed.com.ar/category/covid-19/vacunas/", "https://infomed.com.ar/wp-content/uploads/2021/02/SPUTNIK-V-FASE-3-THE-LANCET.pdf", "https://infomed.com.ar/wp-content/uploads/2021/02/SPUTNIK-V-FASE-3-SAPUE.pdf", "https://www.sg.com.ar/sitio/?ref=infomed", "https://www.ccpbaires.com/?ref=infomed", "https://www.oxynet.com.ar/?utm_source=infomed.com.ar&utm_medium=referral&utm_campaign=infomed_banner", "https://infomed.com.ar/category/nutricion/", "https://infomed.com.ar/nutricion-en-adultos-mayores-vitaminas-y-agua-parte-4-5/", "https://infomed.com.ar/nutricion-en-adultos-mayores-vitaminas-y-agua-parte-4-5/", "https://infomed.com.ar/nutricion-en-adultos-mayores-vitaminas-y-agua-parte-4-5/", "https://infomed.com.ar/nutricion-en-adultos-mayores-vitaminas-y-agua-parte-4-5/", "https://infomed.com.ar/author/ramiro-heredia/", "https://infomed.com.ar/category/covid-19/", "https://infomed.com.ar/covid-19-como-venimos-en-argentina-entrando-en-la-primavera/", "https://infomed.com.ar/covid-19-como-venimos-en-argentina-entrando-en-la-primavera/", "https://infomed.com.ar/covid-19-como-venimos-en-argentina-entrando-en-la-primavera/", "https://infomed.com.ar/covid-19-como-venimos-en-argentina-entrando-en-la-primavera/", "https://infomed.com.ar/author/ramiro-heredia/", "https://infomed.com.ar/category/psicologia/", "https://infomed.com.ar/la-dificil-tarea-de-elegir-una-carrera-universitaria/", "https://infomed.com.ar/la-dificil-tarea-de-elegir-una-carrera-universitaria/", "https://infomed.com.ar/la-dificil-tarea-de-elegir-una-carrera-universitaria/", "https://infomed.com.ar/la-dificil-tarea-de-elegir-una-carrera-universitaria/", "https://infomed.com.ar/author/marcos-tabossi/", "https://infomed.com.ar/category/inmunologia/", "https://infomed.com.ar/category/medicina-interna/", "https://infomed.com.ar/virus-sincicial-respiratorio-vsr-una-nueva-vacuna-en-argentina-copia/", "https://infomed.com.ar/virus-sincicial-respiratorio-vsr-una-nueva-vacuna-en-argentina-copia/", "https://infomed.com.ar/virus-sincicial-respiratorio-vsr-una-nueva-vacuna-en-argentina-copia/", "https://infomed.com.ar/virus-sincicial-respiratorio-vsr-una-nueva-vacuna-en-argentina-copia/", "https://infomed.com.ar/author/ramiro-heredia/", "https://infomed.com.ar/category/infectologia/", "https://infomed.com.ar/henipavirus-que-sabemos-de-esta-familia-de-virus-a-la-que-pertenece-el-nipah-que-genero-casos-recientes-en-india/", "https://infomed.com.ar/henipavirus-que-sabemos-de-esta-familia-de-virus-a-la-que-pertenece-el-nipah-que-genero-casos-recientes-en-india/", "https://infomed.com.ar/henipavirus-que-sabemos-de-esta-familia-de-virus-a-la-que-pertenece-el-nipah-que-genero-casos-recientes-en-india/", "https://infomed.com.ar/henipavirus-que-sabemos-de-esta-familia-de-virus-a-la-que-pertenece-el-nipah-que-genero-casos-recientes-en-india/", "https://infomed.com.ar/author/ramiro-heredia/", "https://infomed.com.ar/category/inmunologia/", "https://infomed.com.ar/category/medicina-interna/", "https://infomed.com.ar/vacuna-contra-el-dengue-en-argentina-se-acerca-el-desembarco-japones-en-la-primavera-2023/", "https://infomed.com.ar/vacuna-contra-el-dengue-en-argentina-se-acerca-el-desembarco-japones-en-la-primavera-2023/", "https://infomed.com.ar/vacuna-contra-el-dengue-en-argentina-se-acerca-el-desembarco-japones-en-la-primavera-2023/", "https://infomed.com.ar/vacuna-contra-el-dengue-en-argentina-se-acerca-el-desembarco-japones-en-la-primavera-2023/", "https://infomed.com.ar/author/ramiro-heredia/", "https://infomed.com.ar/category/infectologia/", "https://infomed.com.ar/virus-usutu-que-sabemos-de-este-virus-que-entro-en-el-radar-de-la-organizacion-panamericana-de-la-salud-ops/", "https://infomed.com.ar/virus-usutu-que-sabemos-de-este-virus-que-entro-en-el-radar-de-la-organizacion-panamericana-de-la-salud-ops/", "https://infomed.com.ar/virus-usutu-que-sabemos-de-este-virus-que-entro-en-el-radar-de-la-organizacion-panamericana-de-la-salud-ops/", "https://infomed.com.ar/virus-usutu-que-sabemos-de-este-virus-que-entro-en-el-radar-de-la-organizacion-panamericana-de-la-salud-ops/", "https://infomed.com.ar/author/ramiro-heredia/", "https://infomed.com.ar/category/medicina-interna/", "https://infomed.com.ar/category/pacientes/", "https://infomed.com.ar/ola-de-frio-polar-un-buen-momento-para-repasar-que-es-la-hipotermia-accidental-segunda-parte/", "https://infomed.com.ar/ola-de-frio-polar-un-buen-momento-para-repasar-que-es-la-hipotermia-accidental-segunda-parte/", "https://infomed.com.ar/ola-de-frio-polar-un-buen-momento-para-repasar-que-es-la-hipotermia-accidental-segunda-parte/", "https://infomed.com.ar/ola-de-frio-polar-un-buen-momento-para-repasar-que-es-la-hipotermia-accidental-segunda-parte/", "https://infomed.com.ar/author/ramiro-heredia/", "https://infomed.com.ar/category/sexologia/", "https://infomed.com.ar/virus-del-papiloma-humano-hpv-en-hombres-mucho-mas-frecuente-de-lo-que-creemos/", "https://infomed.com.ar/virus-del-papiloma-humano-hpv-en-hombres-mucho-mas-frecuente-de-lo-que-creemos/", "https://infomed.com.ar/virus-del-papiloma-humano-hpv-en-hombres-mucho-mas-frecuente-de-lo-que-creemos/", "https://infomed.com.ar/virus-del-papiloma-humano-hpv-en-hombres-mucho-mas-frecuente-de-lo-que-creemos/", "https://infomed.com.ar/author/ramiro-heredia/", "https://infomed.com.ar/category/covid-19/", "https://infomed.com.ar/vacunacion-covid-19-en-argentina-todo-sobre-refuerzos/", "https://infomed.com.ar/vacunacion-covid-19-en-argentina-todo-sobre-refuerzos/", "https://infomed.com.ar/vacunacion-covid-19-en-argentina-todo-sobre-refuerzos/", "https://infomed.com.ar/vacunacion-covid-19-en-argentina-todo-sobre-refuerzos/", "https://infomed.com.ar/author/ramiro-heredia/", "https://www.sanatoriofinochietto.com/?ref=infomed", "https://www.otamendi.com.ar/?ref=infomed", "https://www.cdrossi.com/?ref=infomed", "https://kynet.com.ar/?ref=infomed", "https://www.acudiremergencias.com.ar/?ref=infomed", "https://www.amhc.com.ar/?ref=infomed", "https://www.vocaciondeorientar.ar/?ref=infomed", "https://www.facebook.com/infomedok", "https://twitter.com/infomedok", "https://instagram.com/infomedok", "https://www.youtube.com/channel/UCDHSk_wGGTvl_obKX2VRuEQ", "https://infomed.com.ar/nutricion-en-adultos-mayores-vitaminas-y-agua-parte-4-5/", "https://infomed.com.ar/nutricion-en-adultos-mayores-vitaminas-y-agua-parte-4-5/", "https://infomed.com.ar/category/nutricion/", "https://infomed.com.ar/covid-19-como-venimos-en-argentina-entrando-en-la-primavera/", "https://infomed.com.ar/covid-19-como-venimos-en-argentina-entrando-en-la-primavera/", "https://infomed.com.ar/category/covid-19/", "https://infomed.com.ar/la-dificil-tarea-de-elegir-una-carrera-universitaria/", "https://infomed.com.ar/la-dificil-tarea-de-elegir-una-carrera-universitaria/", "https://infomed.com.ar/category/psicologia/", "https://infomed.com.ar/virus-sincicial-respiratorio-vsr-una-nueva-vacuna-en-argentina-copia/", "https://infomed.com.ar/virus-sincicial-respiratorio-vsr-una-nueva-vacuna-en-argentina-copia/", "https://infomed.com.ar/category/inmunologia/", "https://infomed.com.ar/category/medicina-interna/", "https://infomed.com.ar/henipavirus-que-sabemos-de-esta-familia-de-virus-a-la-que-pertenece-el-nipah-que-genero-casos-recientes-en-india/", "https://infomed.com.ar/henipavirus-que-sabemos-de-esta-familia-de-virus-a-la-que-pertenece-el-nipah-que-genero-casos-recientes-en-india/", "https://infomed.com.ar/category/infectologia/", "https://infomed.com.ar/category/cardiologia/", "https://infomed.com.ar/category/covid-19/", "https://infomed.com.ar/category/covid-19/diagnostico/", "https://infomed.com.ar/category/endocrinologia/", "https://infomed.com.ar/category/gastroenterologia/", "https://infomed.com.ar/category/ginecologia/", "https://infomed.com.ar/category/infectologia/", "https://infomed.com.ar/category/inmunologia/", "https://infomed.com.ar/category/kinesiologia/", "https://infomed.com.ar/category/medicina-del-sueno/", "https://infomed.com.ar/category/medicina-interna/", "https://infomed.com.ar/category/nefrologia/", "https://infomed.com.ar/category/neurologia/", "https://infomed.com.ar/category/nutricion/", "https://infomed.com.ar/category/oncologia/", "https://infomed.com.ar/category/pacientes/", "https://infomed.com.ar/category/pediatria/", "https://infomed.com.ar/category/podcast/", "https://infomed.com.ar/category/politica-sanitaria/", "https://infomed.com.ar/category/covid-19/politicas/", "https://infomed.com.ar/category/covid-19/post-covid/", "https://infomed.com.ar/category/psicologia/", "https://infomed.com.ar/category/psiquiatria/", "https://infomed.com.ar/category/sexologia/", "https://infomed.com.ar/category/tecnologia/", "https://infomed.com.ar/category/toxicologia/", "https://infomed.com.ar/category/covid-19/tratamiento/", "https://infomed.com.ar/category/traumatologia-y-ortopedia/", "https://infomed.com.ar/category/covid-19/vacunas/", "https://infomed.com.ar/category/covid-19/variantes/", "https://infomed.com.ar/category/video/", "https://infomed.com.ar/2023/09/01/", "https://infomed.com.ar/2023/09/02/", "https://infomed.com.ar/2023/09/03/", "https://infomed.com.ar/2023/09/04/", "https://infomed.com.ar/2023/09/05/", "https://infomed.com.ar/2023/09/06/", "https://infomed.com.ar/2023/09/07/", "https://infomed.com.ar/2023/09/08/", "https://infomed.com.ar/2023/09/09/", "https://infomed.com.ar/2023/09/10/", "https://infomed.com.ar/2023/09/11/", "https://infomed.com.ar/2023/09/12/", "https://infomed.com.ar/2023/09/13/", "https://infomed.com.ar/2023/09/14/", "https://infomed.com.ar/2023/09/15/", "https://infomed.com.ar/2023/09/16/", "https://infomed.com.ar/2023/09/18/", "https://infomed.com.ar/2023/09/19/", "https://infomed.com.ar/2023/08/", "https://infomed.com.ar/author/agustin-izaguirre/", "https://infomed.com.ar/author/agustin-izaguirre/", "https://infomed.com.ar/author/alejandra-ferro/", "https://infomed.com.ar/author/alejandra-ferro/", "https://infomed.com.ar/author/ana-cofre/", "https://infomed.com.ar/author/ana-cofre/", "https://infomed.com.ar/author/ana-frydman/", "https://infomed.com.ar/author/ana-frydman/", "https://infomed.com.ar/author/carla-chicco/", "https://infomed.com.ar/author/carla-chicco/", "https://infomed.com.ar/author/cristian-kramer/", "https://infomed.com.ar/author/cristian-kramer/", "https://infomed.com.ar/author/damian-zopatti/", "https://infomed.com.ar/author/damian-zopatti/", "https://infomed.com.ar/author/daniel-samolski/", "https://infomed.com.ar/author/daniel-samolski/", "https://infomed.com.ar/author/deborah-braver/", "https://infomed.com.ar/author/deborah-braver/", "https://infomed.com.ar/author/diego-gonzalez/", "https://infomed.com.ar/author/diego-gonzalez/", "https://infomed.com.ar/author/estefi/", "https://infomed.com.ar/author/estefi/", "https://infomed.com.ar/author/ezequiel-bignasco/", "https://infomed.com.ar/author/ezequiel-bignasco/", "https://infomed.com.ar/author/fabio-clavijo/", "https://infomed.com.ar/author/fabio-clavijo/", "https://infomed.com.ar/author/andres-fadi/", "https://infomed.com.ar/author/andres-fadi/", "https://infomed.com.ar/author/flavio-rotryng/", "https://infomed.com.ar/author/flavio-rotryng/", "https://infomed.com.ar/author/gerardo-santia/", "https://infomed.com.ar/author/gerardo-santia/", "https://infomed.com.ar/author/guido-damianich/", "https://infomed.com.ar/author/guido-damianich/", "https://infomed.com.ar/author/gustavo-kirszner/", "https://infomed.com.ar/author/gustavo-kirszner/", "https://infomed.com.ar/author/hector-gomez/", "https://infomed.com.ar/author/hector-gomez/", "https://infomed.com.ar/author/hector-miguel-perez/", "https://infomed.com.ar/author/hector-miguel-perez/", "https://infomed.com.ar/author/hernan-jamui/", "https://infomed.com.ar/author/hernan-jamui/", "https://infomed.com.ar/author/infomed/", "https://infomed.com.ar/author/infomed/", "https://infomed.com.ar/author/ivan-constantin/", "https://infomed.com.ar/author/ivan-constantin/", "https://infomed.com.ar/author/javier-livov/", "https://infomed.com.ar/author/javier-livov/", "https://infomed.com.ar/author/maria-feijoo/", "https://infomed.com.ar/author/maria-feijoo/", "https://infomed.com.ar/author/magdalena-casas/", "https://infomed.com.ar/author/magdalena-casas/", "https://infomed.com.ar/author/mailen-linari/", "https://infomed.com.ar/author/mailen-linari/", "https://infomed.com.ar/author/manuel-clavijo/", "https://infomed.com.ar/author/manuel-clavijo/", "https://infomed.com.ar/author/marcelo-radisic/", "https://infomed.com.ar/author/marcelo-radisic/", "https://infomed.com.ar/author/marcelo-rio/", "https://infomed.com.ar/author/marcelo-rio/", "https://infomed.com.ar/author/marcos-tabossi/", "https://infomed.com.ar/author/marcos-tabossi/", "https://infomed.com.ar/author/maria-ermida/", "https://infomed.com.ar/author/maria-ermida/", "https://infomed.com.ar/author/caamano/", "https://infomed.com.ar/author/caamano/", "https://infomed.com.ar/author/melisa-antoniolli/", "https://infomed.com.ar/author/melisa-antoniolli/", "https://infomed.com.ar/author/natalia-santos/", "https://infomed.com.ar/author/natalia-santos/", "https://infomed.com.ar/author/nicolas-gonzalez/", "https://infomed.com.ar/author/nicolas-gonzalez/", "https://infomed.com.ar/author/pablo-baccaglio/", "https://infomed.com.ar/author/pablo-baccaglio/", "https://infomed.com.ar/author/paola-brunetti/", "https://infomed.com.ar/author/paola-brunetti/", "https://infomed.com.ar/author/ramiro-heredia/", "https://infomed.com.ar/author/ramiro-heredia/", "https://infomed.com.ar/author/roberto-campos/", "https://infomed.com.ar/author/roberto-campos/", "https://infomed.com.ar/author/roberto-rey/", "https://infomed.com.ar/author/roberto-rey/", "https://infomed.com.ar/author/rodny/", "https://infomed.com.ar/author/rodny/", "https://infomed.com.ar/author/romina-mauas/", "https://infomed.com.ar/author/romina-mauas/", "https://infomed.com.ar/author/ruben-torres/", "https://infomed.com.ar/author/ruben-torres/", "https://infomed.com.ar/author/santiago-foti/", "https://infomed.com.ar/author/santiago-foti/", "https://infomed.com.ar/author/santiago-vommaro/", "https://infomed.com.ar/author/santiago-vommaro/", "https://infomed.com.ar/author/valeria-caracoche/", "https://infomed.com.ar/author/valeria-caracoche/", "https://infomed.com.ar/author/veronica-t/", "https://infomed.com.ar/author/veronica-t/", "https://infomed.com.ar/author/virginia-kuperstein/", "https://infomed.com.ar/author/virginia-kuperstein/", "https://infomed.com.ar/tag/anticuerpos/", "https://infomed.com.ar/tag/argentina/", "https://infomed.com.ar/tag/cardiologia/", "https://infomed.com.ar/tag/covid/", "https://infomed.com.ar/tag/covid-prolongado/", "https://infomed.com.ar/tag/cancer/", "https://infomed.com.ar/tag/dengue/", "https://infomed.com.ar/tag/golpe-de-calor/", "https://infomed.com.ar/tag/omicron/", "https://infomed.com.ar/tag/pacientes/", "https://infomed.com.ar/tag/pandemia/", "https://infomed.com.ar/tag/post-covid/", "https://infomed.com.ar/tag/psicologia/", "https://infomed.com.ar/tag/tratamiento/", "https://infomed.com.ar/tag/vacuna/", "https://infomed.com.ar/tag/vacunacion/", "https://infomed.com.ar/tag/vacunas/", "https://infomed.com.ar/tag/vacunas-covid/", "https://infomed.com.ar/tag/variantes/", "https://infomed.com.ar/tag/viruela-del-mono/", "https://infomed.com.ar/nutricion-en-adultos-mayores-vitaminas-y-agua-parte-4-5/", "https://infomed.com.ar/covid-19-como-venimos-en-argentina-entrando-en-la-primavera/", "https://infomed.com.ar/la-dificil-tarea-de-elegir-una-carrera-universitaria/", "https://infomed.com.ar/virus-sincicial-respiratorio-vsr-una-nueva-vacuna-en-argentina-copia/", "https://infomed.com.ar/henipavirus-que-sabemos-de-esta-familia-de-virus-a-la-que-pertenece-el-nipah-que-genero-casos-recientes-en-india/", "https://infomed.com.ar/vacuna-sinopharm-para-ninos-y-adolescentes-cual-es-la-ultima-evidencia/#comment-221", "https://infomed.com.ar/vacuna-sinopharm-para-ninos-y-adolescentes-cual-es-la-ultima-evidencia/#comment-220", "https://infomed.com.ar/golpes-de-calor-informacion-para-pacientes/#comment-122", "https://infomed.com.ar/golpes-de-calor-informacion-para-pacientes/#comment-121", "https://infomed.com.ar/vacuna-sinopharm-para-ninos-y-adolescentes-cual-es-la-ultima-evidencia/#comment-120", "http://www.elegantthemes.com", "http://www.wordpress.org", "https://facebook.com/infomedok", "https://twitter.com/infomedok", "https://instagram.com/infomedok", "https://www.youtube.com/channel/UCDHSk_wGGTvl_obKX2VRuEQ", "http://twitter.com/share?text=Seguridad%20y%20eficacia%20de%20una%20vacuna%20COVID%2019%20prime-boost%20heter%C3%B3loga%2C%20basada%20en%20un%20vector%20rAd26%20y%20rAd5%3A%20un%20an%C3%A1lisis%20provisional%20de%20un%20ensayo%20de%20fase%203%2C%20controlado%2C%20aleatorio%2C%20en%20Rusia&url=https%3A%2F%2Finfomed.com.ar%2Fseguridad-y-eficacia-de-una-vacuna-covid-19-prime-boost-heterologa-basada-en-un-vector-rad26-y-rad5-un-analisis-provisional-de-un-ensayo-de-fase-3-controlado-aleatorio-en-rusia%2F", "http://www.facebook.com/sharer.php?u=https%3A%2F%2Finfomed.com.ar%2Fseguridad-y-eficacia-de-una-vacuna-covid-19-prime-boost-heterologa-basada-en-un-vector-rad26-y-rad5-un-analisis-provisional-de-un-ensayo-de-fase-3-controlado-aleatorio-en-rusia%2F&t=Seguridad%20y%20eficacia%20de%20una%20vacuna%20COVID%2019%20prime-boost%20heter%C3%B3loga%2C%20basada%20en%20un%20vector%20rAd26%20y%20rAd5%3A%20un%20an%C3%A1lisis%20provisional%20de%20un%20ensayo%20de%20fase%203%2C%20controlado%2C%20aleatorio%2C%20en%20Rusia", "https://mail.google.com/mail/u/0/?view=cm&fs=1&su=Seguridad%20y%20eficacia%20de%20una%20vacuna%20COVID%2019%20prime-boost%20heter%C3%B3loga%2C%20basada%20en%20un%20vector%20rAd26%20y%20rAd5%3A%20un%20an%C3%A1lisis%20provisional%20de%20un%20ensayo%20de%20fase%203%2C%20controlado%2C%20aleatorio%2C%20en%20Rusia&body=https%3A%2F%2Finfomed.com.ar%2Fseguridad-y-eficacia-de-una-vacuna-covid-19-prime-boost-heterologa-basada-en-un-vector-rad26-y-rad5-un-analisis-provisional-de-un-ensayo-de-fase-3-controlado-aleatorio-en-rusia%2F&ui=2&tf=1", "http://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Finfomed.com.ar%2Fseguridad-y-eficacia-de-una-vacuna-covid-19-prime-boost-heterologa-basada-en-un-vector-rad26-y-rad5-un-analisis-provisional-de-un-ensayo-de-fase-3-controlado-aleatorio-en-rusia%2F&title=Seguridad%20y%20eficacia%20de%20una%20vacuna%20COVID%2019%20prime-boost%20heter%C3%B3loga%2C%20basada%20en%20un%20vector%20rAd26%20y%20rAd5%3A%20un%20an%C3%A1lisis%20provisional%20de%20un%20ensayo%20de%20fase%203%2C%20controlado%2C%20aleatorio%2C%20en%20Rusia", "#", "http://twitter.com/share?text=Seguridad%20y%20eficacia%20de%20una%20vacuna%20COVID%2019%20prime-boost%20heter%C3%B3loga%2C%20basada%20en%20un%20vector%20rAd26%20y%20rAd5%3A%20un%20an%C3%A1lisis%20provisional%20de%20un%20ensayo%20de%20fase%203%2C%20controlado%2C%20aleatorio%2C%20en%20Rusia&url=https%3A%2F%2Finfomed.com.ar%2Fseguridad-y-eficacia-de-una-vacuna-covid-19-prime-boost-heterologa-basada-en-un-vector-rad26-y-rad5-un-analisis-provisional-de-un-ensayo-de-fase-3-controlado-aleatorio-en-rusia%2F", "http://www.facebook.com/sharer.php?u=https%3A%2F%2Finfomed.com.ar%2Fseguridad-y-eficacia-de-una-vacuna-covid-19-prime-boost-heterologa-basada-en-un-vector-rad26-y-rad5-un-analisis-provisional-de-un-ensayo-de-fase-3-controlado-aleatorio-en-rusia%2F&t=Seguridad%20y%20eficacia%20de%20una%20vacuna%20COVID%2019%20prime-boost%20heter%C3%B3loga%2C%20basada%20en%20un%20vector%20rAd26%20y%20rAd5%3A%20un%20an%C3%A1lisis%20provisional%20de%20un%20ensayo%20de%20fase%203%2C%20controlado%2C%20aleatorio%2C%20en%20Rusia", "https://mail.google.com/mail/u/0/?view=cm&fs=1&su=Seguridad%20y%20eficacia%20de%20una%20vacuna%20COVID%2019%20prime-boost%20heter%C3%B3loga%2C%20basada%20en%20un%20vector%20rAd26%20y%20rAd5%3A%20un%20an%C3%A1lisis%20provisional%20de%20un%20ensayo%20de%20fase%203%2C%20controlado%2C%20aleatorio%2C%20en%20Rusia&body=https%3A%2F%2Finfomed.com.ar%2Fseguridad-y-eficacia-de-una-vacuna-covid-19-prime-boost-heterologa-basada-en-un-vector-rad26-y-rad5-un-analisis-provisional-de-un-ensayo-de-fase-3-controlado-aleatorio-en-rusia%2F&ui=2&tf=1", "http://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Finfomed.com.ar%2Fseguridad-y-eficacia-de-una-vacuna-covid-19-prime-boost-heterologa-basada-en-un-vector-rad26-y-rad5-un-analisis-provisional-de-un-ensayo-de-fase-3-controlado-aleatorio-en-rusia%2F&title=Seguridad%20y%20eficacia%20de%20una%20vacuna%20COVID%2019%20prime-boost%20heter%C3%B3loga%2C%20basada%20en%20un%20vector%20rAd26%20y%20rAd5%3A%20un%20an%C3%A1lisis%20provisional%20de%20un%20ensayo%20de%20fase%203%2C%20controlado%2C%20aleatorio%2C%20en%20Rusia", "#", "https://www.unibrand.com.ar/?ref=infomed"]}